Teriparatide
( DrugBank: Teriparatide / KEGG DRUG: Teriparatide acetate, Teriparatide, Teriparatide acetate )
7 diseases
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 46 | 悪性関節リウマチ | 1 |
| 68 | 黄色靱帯骨化症 | 1 |
| 70 | 広範脊柱管狭窄症 | 4 |
| 71 | 特発性大腿骨頭壊死症 | 1 |
46. 悪性関節リウマチ
臨床試験数 : 4,743 / 薬物数 : 3,042 - (DrugBank : 389) / 標的遺伝子数 : 205 - 標的パスウェイ数 : 253
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
68. 黄色靱帯骨化症
臨床試験数 : 2 / 薬物数 : 4 - (DrugBank : 4) / 標的遺伝子数 : 1 - 標的パスウェイ数 : 4
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
70. 広範脊柱管狭窄症
臨床試験数 : 146 / 薬物数 : 244 - (DrugBank : 71) / 標的遺伝子数 : 96 - 標的パスウェイ数 : 110
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
71. 特発性大腿骨頭壊死症
臨床試験数 : 45 / 薬物数 : 49 - (DrugBank : 23) / 標的遺伝子数 : 15 - 標的パスウェイ数 : 40
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
172. 低ホスファターゼ症
臨床試験数 : 45 / 薬物数 : 38 - (DrugBank : 8) / 標的遺伝子数 : 6 - 標的パスウェイ数 : 18
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
235. 副甲状腺機能低下症
臨床試験数 : 120 / 薬物数 : 167 - (DrugBank : 31) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 7
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
274. 骨形成不全症
臨床試験数 : 108 / 薬物数 : 113 - (DrugBank : 18) / 標的遺伝子数 : 9 - 標的パスウェイ数 : 51
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|